The purpose of this study is to assess the severity of portal hypertension in people with compensated advanced chronic liver disease (cACLD) who have not undergone liver transplant by measuring liver stiffness with the Liver Incytes device and to compare the performance of LSM (liver stiffness measurement) by Liver Incytes for predicting clinically significant portal hypertension CSPH, esophageal and gastric varices to that of FibroScan® and other non-invasive blood markers such as MELD, CPT, platelets count, splenomegaly (enlarged spleen), APRI and FIB4.
This is a cross sectional study that evaluates the relationship between LSM (liver stiffness measurement) by Liver Incytes in patients with cACLD (compensated advanced chronic liver disease) and manifestations of portal hypertension.